Bharat Biotech’s Covaxin is overall 77.8 per cent effective against Covid, the vaccine maker said today in a statement, citing the data from the third phase of clinical trials. The data, however, is yet to be peer-reviewed. The vaccine offers “65.2 per cent protection”, it said, against the rapidly…
Bharat Biotech and the World Health Organization held a ‘pre-submission’ meeting on Wednesday for international emergency use listing (EUL) of Covaxin, its COVID-19 vaccine. The meeting was to give the company a chance to receive guidance from WHO authorities before the final submission. No details…
Vaccine manufacturer Bharat Biotech has said the rate at which it was supplying its Covid-19 vaccine to the government was “not sustainable in the long run” and a differential price in the private markets was justified to “offset parts of the costs”. In a detailed statement over the pricing…
India has cumulatively administered more than 20 crore vaccine doses up till 7 pm on May 25, reported news agency ANI. As many as 20,04,94,991 vaccine jabs have been administered as of May 25. The daily count of coronavirus cases in the country fell below the 2-lakh mark after over a month taking the total tally of…
The World Health Organisation (WHO) has said that “more information” is “required” from Bharat Biotech, which is seeking emergency use listing (EUL) for its Covaxin vaccine for Covid-19. The latest ‘Status of Covid-19 Vaccines within WHO EUL/PQ evaluation process’ guidance document dated May 18 on the WHO…